Battling Alzheimer’s Disease: then and Now
Alzheimer’s disease (AD) is a chronic illness of extreme neural atrophy characterized by extensive memory loss, disorientation, and labored social communication/behavior. Often beginning after 65 years of age, AD constitutes between 60“70% of all dementia cases (Duthey 6) and, by extension, afflicts between 35“50 million globally at any given time (Park). The tracking of AD is largely an arduous task, even with sophisticated neuroimaging such as tensor-based morphometry and cortical thickness mapping; however, due to its devastating toll, a treatment […]